Your browser doesn't support javascript.
loading
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.
Oxley, Samuel; Kalra, Ashwin; Sideris, Michail; Itzkowitz, Nicole; Evans, Olivia; Atakpa, Emma Christine; Brentnall, Adam R; Dworschak, Nina; Gaba, Faiza; Gabe, Rhian; Sundar, Sudha; Wood, Nick; Nicum, Shibani; Taylor, Alexandra; Dobbs, Stephen; McCluggage, W Glenn; Nordin, Andy; Legood, Rosa; Kehoe, Sean; Ghaem-Maghami, Sadaf; Manchanda, Ranjit.
Affiliation
  • Oxley S; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Kalra A; Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Sideris M; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Itzkowitz N; Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Evans O; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Atakpa EC; Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Brentnall AR; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Dworschak N; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Gaba F; Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Gabe R; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Sundar S; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Wood N; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • Nicum S; Department of Gynaecological Oncology, Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.
  • Taylor A; Institute of Applied Health Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK.
  • Dobbs S; Wolfson Institute of Population Health, Cancer Research UK, Barts Centre, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
  • McCluggage WG; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Nordin A; Lancashire Teaching Hospitals NHS Foundation Trust, Preston PR2 9HT, UK.
  • Legood R; Institute of Cancer Research, University College London, London WC1E 6DD, UK.
  • Kehoe S; Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Ghaem-Maghami S; Belfast City Hospital, Belfast Health and Social Care Trust, Belfast BT9 7AB, UK.
  • Manchanda R; Department of Pathology, Belfast Health and Social Care Trust, Belfast BT12 6BA, UK.
Cancers (Basel) ; 15(4)2023 Feb 16.
Article de En | MEDLINE | ID: mdl-36831615
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2023 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Suisse